Otsuka Pharmaceutical Co., Ltd.

GPTKB entity

Statements (50)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkb:public_company
gptkbp:CEO gptkb:Makoto_Inoue
gptkbp:country gptkb:Japan
gptkbp:focus pharmaceuticals
medical devices
consumer products
nutraceuticals
gptkbp:foundedIn 1964
gptkbp:founder gptkb:Busaburo_Otsuka
gptkbp:headquartersLocation gptkb:Tokushima,_Japan
gptkb:Tokyo,_Japan
https://www.w3.org/2000/01/rdf-schema#label Otsuka Pharmaceutical Co., Ltd.
gptkbp:industry pharmaceuticals
nutraceuticals
gptkbp:ISIN JP3188220002
gptkbp:listedOn gptkb:Tokyo_Stock_Exchange
gptkbp:market global
gptkbp:memberOf gptkb:Japan_Pharmaceutical_Manufacturers_Association
gptkbp:notable_drug gptkb:Rexulti
gptkb:Samsca
gptkb:Abilify
gptkbp:notableBeverage gptkb:Oronamin_C
gptkb:Pocari_Sweat
gptkbp:notableProduct gptkb:Abilify
gptkb:Oronamin_C
gptkb:Pocari_Sweat
gptkbp:numberOfEmployees over 30,000
gptkbp:parentCompany gptkb:Otsuka_Holdings_Co.,_Ltd.
gptkbp:products gptkb:Rexulti
gptkb:Samsca
gptkb:Abilify
gptkb:Oronamin_C
gptkb:Pocari_Sweat
gptkbp:researchInterest oncology
cardiovascular diseases
nutritional science
CNS disorders
gptkbp:revenue over 1 trillion yen (Otsuka Holdings, 2022)
gptkbp:servesArea worldwide
gptkbp:slogan Otsuka-people creating new products for better health worldwide
gptkbp:stockExchange gptkb:Tokyo_Stock_Exchange
gptkbp:stockSymbol 4578
gptkbp:subsidiary gptkb:Otsuka_Pharmaceutical_Europe_Ltd.
gptkb:Taiho_Pharmaceutical
gptkb:Otsuka_America_Pharmaceutical,_Inc.
gptkbp:website https://www.otsuka.co.jp/en/
gptkbp:bfsParent gptkb:Otsuka
gptkb:Otsuka_Holdings
gptkbp:bfsLayer 6